We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 1.55% | 1.31 | 1.282 | 1.338 | 1.326 | 1.272 | 1.29 | 5,347,757 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -6.69M | -0.0050 | -2.60 | 17.44M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2020 11:33 | Er, this company is nothing to do with covid 😂 | davevt | |
22/4/2020 11:33 | digitt, The RNS mentions that this is concurrent to the other projects, which we know are in the hands of Orgenesis/Belgian government and Globalco(s) "This development is an application of the Company's existing work, taking place alongside its long-term development of new treatments for blood and autoimmune diseases, which remain on track. " | on target | |
22/4/2020 11:32 | take a look at other covid 19 stocks - mkt cap tiny here. | pre | |
22/4/2020 11:31 | Big news? What are you talking about? It's only a patent issuance, and Cornell own the patent. | davevt | |
22/4/2020 11:31 | Words from the most infamous deramper....somethin | zen12 | |
22/4/2020 11:30 | That's exactly what I invested in and am waiting for, and have had the same concerns as many on lack of comms from the company. But I worry the COVID stuff is purely jumping on the bandwagon to get a share price back to where it was a year or so ago, with nothing really behind it. ie so likely to unwind, while at the same time possibly distracting us from the initial plan. Will be ecstatic to be proven wrong and do enjoy being less out of the money though. I'm still waiting for my Kickstarter humanized mouse to arrive in the post. | digittt | |
22/4/2020 11:29 | Overhang 2.2p to buy when 2.2-2.35p spread but it's going to clear quickly at this rate buys are flying in | dave4545 | |
22/4/2020 11:29 | big news for such a small cap, this will follow others involved in covid 19, start of the journey..100k buys | pre | |
22/4/2020 11:26 | Ohh and here is yesterdays seller diddums | knowing | |
22/4/2020 11:26 | On Target - my buy price at 1.7p sell few at 2.15 few at 2.1 But as i say, i learned. if you wont sell then this back to 1.5 or even 1P | idontflykathyy | |
22/4/2020 11:25 | LOL W*nker | knowing | |
22/4/2020 11:24 | Nothing concrete discovered | costax1654x | |
22/4/2020 11:24 | LOL, poor Kathy has sold at the wrong time again. | on target | |
22/4/2020 11:23 | digitt Did you see Nsci Rns, there's was nothing much and it went from 5p to 20p...of course it went all the way back down too but the momentum could take this to 5p later on | dave4545 | |
22/4/2020 11:22 | Those who wont sell in this opportunity must themselves to blame. I repeast - READ RNS AGAIN NOTHING!!!! | idontflykathyy | |
22/4/2020 11:19 | I just sold a nice little chunk at 2.2 | davevt | |
22/4/2020 11:19 | Not to mention AML and bone marrow treatment (no more chemo/radiotherapy) CDX which is approaching clinical trial ready. Just waiting for 'globalco' licencing RNS on that and ££££. | on target | |
22/4/2020 11:18 | Am I missing something or is the RNS not saying much? Just that Hemo will work on something. Nothing concrete discovered in essence? As jaded and cynical as I sound, this bump finally puts me in positive territory after a long hold, so I'm happy...I'm just confused and about to give up trying to interpret this market. Made the mistake of looking at the live price and now I'm in the red again...boo! | digittt | |
22/4/2020 11:18 | Very low mcap for current patents. Future patents and potential of its mice. | orchestralis | |
22/4/2020 11:16 | Plus the 36.000.000 mil Placing at 1.8!!Be smart | costax1654x | |
22/4/2020 11:15 | Shnuckums Costa der der move on | knowing | |
22/4/2020 11:14 | This is now 'in play'. The days of tiny volumes and drifting down are gone. | on target | |
22/4/2020 11:13 | COVID-19 Project Initiated Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is deploying its groundbreaking research and technologies to develop potential treatments for COVID-19. Concurrently.. Hemogenyx will aim to develop and commercialize a test that could identify people with potentially high/low risk of severe illness caused by the virus. | on target | |
22/4/2020 11:11 | Read the RNS | costax1654x |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions